OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2026-01-01-accounts

2

Trustees’ Annual Report for the period

From 01/01/2025 Period start date To 31/12/2025 Period end date

Charity name: NTM NETWORK UK

Charity registration number: 1207531

Objectives and Activities

Objectves and Actvites
SORP
reference
Summary of the
purposes of the
charity as set out in its
governing document
Para 1.17 NTM Network UK was established in December 2014 in
response to the need for improved management of the rising
number of NTM isolates identfed in clinical practce. It
provides a framework within which NTM infectons and
disease can be systematcally investgated, researched and
managed.
NTM Network UK aims to:

Consolidate the mult-disciplinary expertse available to
develop standardised, cost-efectve methods and tools to
identfy NTM, and to improve NTM infecton and disease
diagnosis and management.

Standardise clinical practce and data collecton, including
clinical assessments, microbiology, immunology,
radiology, health status/quality of life scores and
outcomes.

Develop protocols for data collecton, clinical sampling,
and sample storage (to include sputum, blood, laboratory
and imaging data).

Obtain mult-centre ethical approval to enable data
collecton and long-term projects to take place.

Develop a harmonised database of NTM patents for
clinical use and research analysis.

Evaluate the process and outputs of the research
actvites.

Support new areas of research, actvites and events
proposed by members.

Assess and support the development of collaboratons and
interactons within NTM Network UK, and with other
research organisatons and clinical groupings.

Work to make public health surveillance of NTM more
robust.

Assist with resolving strategic level local and regional
issues and risks.

Support the UK patent associaton, NTM Patent Care UK,
in achieving its charitable aims.

Support and provide educatonal actvites in the feld of
NTM.
Summary of the main
actvites in relaton to
those purposes for the
public beneft, in
partcular, the
actvites, projects or
services identfed in
the accounts.
Para 1.17
and 1.19
Main actvites for this reportng period include the following:
a)
NTM Network UK has held Quarterly Members Meetngs
to update members on Network actvites, share reports
from specialist interest groups, and hear presentatons
from invited guest speakers. These meetngs promote
collaboraton, educaton, and knowledge sharing among
healthcare professionals involved in the care of people
with NTM disease.
b)
NTM Network UK has held Management Group Meetngs
every 6 months to review progress, oversee ongoing
projects, and plan future actvites in line with the charity’s
strategic objectves.
c)
NTM Network UK held an Annual Meetng (23/10/2025)
during which Network membership, output and funding
were all reviewed and objectves were set for the year
ahead
d)
NTM Network UK has produced The Patent’s Guide to
NTM Standards of Care in conjuncton with NTM Patent
Care UK
e)
NTM Network UK supported NTM research by submitng
a manuscript for publicaton (under review) on a Natonal
Audit of Clinical Practce
f)
The Pharmacy Interest Group fnalised and published the
NTM Monographs (htps://www.ntmnetworkuk.com/ntm-
drug-monographs
)
g)
The Extrapulmonary NTM (EPNTM) Interest Group has
initated a Natonal Clinical Advice Service for EPNTM
h)
The Nursing Interest Group has held regular educatonal
sessions to discuss complex cases as well as providing
advice and peer support
i)
Across these actvites, NTM Network UK has aimed to
improve outcomes for people with NTM disease in the UK,
by strengthening collaboraton between healthcare
professionals, promotng consistency and quality in clinical
care, and supportng educaton and research.
Statement confrming
whether the trustees
have had regard to
the guidance issued
by the Charity
Commission on public
beneft
Para 1.18 The trustees have had regard to the Charity Commission’s
guidance on public beneft.

Additional information (optional)

You may choose to include further statements where relevant about:

SORP
reference
Policy on grant
making
Para 1.38 N/A
Policy on social
investment
including program
related investment
Para 1.38 N/A
Contributon made
by volunteers
Para 1.38 All actvites undertaken by NTM Network UK during the
reportng period were delivered through the work of volunteers.
The Network’s members, including clinicians, pharmacists,
scientsts, and other healthcare professionals, contributed their
tme and expertse for free in developing the materials produced
by NTM Network UK. The charity’s ability to deliver these
outputs relies entrely on the ongoing commitment and goodwill
of its volunteer members.
Other N/A

Achievements and Performance

SORP
reference
Summary of the main
achievements of the charity,
identfying the diference the
charity’s work has made to
the circumstances of its
benefciaries and any wider
benefts to society as a
whole.
Para 1.20 Main achievements for this reportng period include the
following:
a)
NTM Network UK has produced The Patent’s Guide
to NTM Standards of Care in conjuncton with NTM
Patent Care UK
b)
NTM Network UK has developed patent and
clinician checklists covering new diagnosis and
outpatent management
c)
Development of scientfc abstracts to share fndings
with the wider healthcare community, including
analysis of the use of bedaquiline in NTM treatment

Additional information (optional)

You may choose to include further statements where relevant about:

Achievements against objectves set Para 1.41 N/A
Performance of fundraising actvites against objectves set Para 1.41 N/A
Investment performance against objectves Para 1.41 N/A
Other N/A

Financial Review

Review of the charity’s fnancial
positon at the end of the
period
Para
1.21
The charity is in positve balance.
The charity did not carry forward any income or expenses
from theprevious NTM Network UK actvites
Statement explaining the policy
for holding reserves statng
why they are held
Para
1.22
The Charity has no policy for holding reserves and a policy
is not considered necessary at this tme as the charity
contnued to require limited spending during this
reportng period.
Amount of reserves held Para
1.22
NA
Reasons for holding zero
reserves
Para
1.22
The charity has had very limited spending over the
reportng period, so reserves are not considered
necessary.
Details of fund materially in
defcit
Para
1.24
N/A
Explanaton of any
uncertaintes about the charity
contnuingas agoingconcern
Para
1.23
N/A

Additional information (optional)

You may choose to include further statements where relevant about:

The charity’s principal
sources of funds
(includingany
Para
1.47
The charity had a positve balance of £15,581.34 at the end of this
period. Income had been received via fundraising undertaken by
members of the NTM Network undertakingsponsored events. We
fundraising) received £4500 from the pharmaceutcal company Shionogi B.V in
support of our Annual Meetng which enabled us to invite world-
leading experts in NTM to partcipate in a panel discussion
Investment policy and
objectves including
any social investment
policyadopted
Para
1.46
N/A
A descripton of the
principal risks facing
the charity
Para
1.46
N/A
Other N/A

Structure, Governance and Management

Structure, Governance and Management
Descripton of charity’s trusts: N/A
Type of governing document
(trust deed, royal charter)
Para
1.25
Consttuton of the Charitable
Incorporated Organisaton (CIO)
How is the charity consttuted?
(e.g unincorporated associaton, CIO)
Para
1.25
Charitable Incorporated Organisaton
(CIO)
Trustee selecton methods including details of
any consttutonal provisions e.g. electon to post
or name of any person or body enttled to
appoint one or more trustees
Para
1.25
Trustees include founding individuals
and healthcare professionals, to ensure
the best representaton of professionals
in NTM care.

Additional information (optional)

You may choose to include further statements where relevant about:

Additonal informaton (optonal)
You maychoose to include further statements where relevant about:
Policies and procedures adopted for the inducton and training of trustees Para
1.51
N/A
The charity’s organisatonal structure and any wider network with which the
charity works
Para
1.51
N/A
Relatonship with any related partes Para
1.51
N/A
Other N/A

Reference and Administrative details

Charityname NTM Network UK
Other name the charity
uses
N/A
Registered charity
number
Charity’s principal
address
1207531
Royal Free London NHS Foundaton Trust, Pond St, Hampstead, London
NW3 2QG

Names of the charity trustees who manage the charity during period of report

Trustee Name Ofce (if any) Dates acted if not for
whole year
Name of person (or
body) enttled to
appoint trustee (if
any)
Marc Lipman Trustee
Ronan Breen Trustee
Ibrahim Abubakar Trustee
Jennie Keane Trustee
Lisa Morrison Trustee

Corporate trustees – names of the directors at the date the report was approved

Director name N/A

Name of trustees holding title to property belonging to the charity

Trustee name
N/A
Dates acted if not for wholeyear

Funds held as custodian trustees on behalf of others

Descripton of the assets held in this capacity
Name and objects of the charity on whose behalf the assets are held and how this falls within
the custodian charity’s objects
Details of arrangements for safe custody and segregaton of such assets from the charity’s
own assets
N/A
N/A
N/A

Additional information (optional)

Names and addresses of advisers (Optional information)

onal informaton (optonal)
Names and addresses of advisers (Optonal informaton)
onal informaton (optonal)
Names and addresses of advisers (Optonal informaton)
Type of adviser
Name
Address
Type of adviser
Name
Address
N/A

Name of chief executive or names of senior staff members (Optional information) N/A

Exemptions from disclosure

Reason for non-disclosure of key personnel details

N/A

Other optional information N/A

Declarations

The trustees declare that they have approved the trustees’ report above.

Signed on behalf of the charity’s trustees

Signature(s) Full name(s) Ronan Angus MacCormick Breen Position (eg Secretary, Chair, etc) Vice-Chair Date 31/10/2026